Hysteroscopic follow-up during Tamoxifen treatment
- 1 May 1990
- journal article
- research article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 35 (2-3) , 235-238
- https://doi.org/10.1016/0028-2243(90)90167-y
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- TAMOXIFEN AND THE UTERUS AND ENDOMETRIUMThe Lancet, 1989
- ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERSThe Lancet, 1989
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- TAMOXIFEN AS RISK FACTOR FOR CARCINOMA OF CORPUS UTERIThe Lancet, 1988
- TAMOXIFEN AND BENIGN BREAST PROBLEMSThe Lancet, 1987
- Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifenAtherosclerosis, 1984
- INCREASES IN STEROID BINDING GLOBULINS INDUCED BY TAMOXIFEN IN PATIENTS WITH CARCINOMA OF THE BREASTJournal of Endocrinology, 1978
- Oestrogen-like effect of tamoxifen on vaginal epithelium.BMJ, 1977